{"id":561813,"date":"2025-10-15T16:50:45","date_gmt":"2025-10-15T16:50:45","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/561813\/recombinant-proteins-market-to-reach-usd-32-billion-by-2028-driven-by-growing-demand-for-biologics-and-personalized-medicine.html"},"modified":"2025-10-15T16:50:45","modified_gmt":"2025-10-15T16:50:45","slug":"recombinant-proteins-market-to-reach-usd-32-billion-by-2028-driven-by-growing-demand-for-biologics-and-personalized-medicine","status":"publish","type":"post","link":"https:\/\/www.olympiajournal.com\/news\/story\/561813\/recombinant-proteins-market-to-reach-usd-32-billion-by-2028-driven-by-growing-demand-for-biologics-and-personalized-medicine.html","title":{"rendered":"Recombinant Proteins Market to Reach USD 3.2 Billion by 2028, Driven by Growing Demand for Biologics and Personalized Medicine"},"content":{"rendered":"
\n
\"Recombinant<\/a><\/div>\n
\n
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region – Global Forecast to 2028<\/div>\n<\/div>\n<\/div>\n
Asia Pacific market is estimated to witness the highest CAGR in recombinant proteins market during the forecast period.<\/div>\n

According to the latest report by MarketsandMarkets™<\/strong>, the global recombinant proteins market<\/strong> was valued at USD 2.2 billion in 2023<\/strong> and is projected to reach USD 3.2 billion by 2028<\/strong>, growing at a CAGR of 7.2%<\/strong> during the forecast period (2023–2028).<\/p>\n

This market growth is primarily attributed to the rising incidence of chronic diseases<\/strong>, increasing demand for biologics and biosimilars due to patent expirations<\/strong>, government support for life sciences R&D<\/strong>, and a growing focus on personalized medicine<\/strong>. These factors collectively underscore the pivotal role of recombinant proteins in advancing therapeutic development, precision medicine, and biomedical research.<\/p>\n

Download PDF Brochure: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=70095015<\/a><\/strong><\/p>\n

Market Insights and Segment Highlights<\/strong>Growth Factors & Chemokines Segment Dominates the Market<\/strong><\/p>\n

By product, the recombinant proteins market is categorized into growth factors and chemokines<\/strong>, immune response proteins<\/strong>, structural proteins<\/strong>, membrane proteins<\/strong>, kinase proteins<\/strong>, regulatory proteins<\/strong>, metabolic enzymes<\/strong>, adhesion molecules & receptors<\/strong>, and others<\/strong>.<\/p>\n

In 2023, the growth factors and chemokines segment<\/strong>—including interferons and interleukins—held the largest market share<\/strong>. Their extensive use across diverse research areas such as neurobiology, immunology, wound healing, cancer, HIV\/AIDS, cell culture<\/strong>, and stem cell research<\/strong> drives their strong demand and market dominance.<\/p>\n

Discovery & Development Leads by Application<\/strong><\/p>\n

Based on application, the market is segmented into drug discovery & development, biopharmaceutical production, research, diagnostics,<\/strong> and others<\/strong>.<\/p>\n

The drug discovery & development segment<\/strong>—further classified into biologics, vaccines, and cell & gene therapy—accounted for the largest share in 2023<\/strong>. The segment’s growth is driven by the use of recombinant proteins in screening novel compounds<\/strong> that modulate disease-related protein functions, coupled with increased investments in R&D<\/strong> focused on next-generation therapeutics.<\/p>\n

Bacterial Cells Remain the Preferred Host System<\/strong><\/p>\n

By host cell, the recombinant proteins market is segmented into mammalian systems, insect cells, yeast & fungi, bacterial cells,<\/strong> and other hosts<\/strong>.<\/p>\n

In 2022, the bacterial cell segment<\/strong> dominated the market, attributed to its ease of genetic manipulation, cost-effectiveness<\/strong>, and high yield capabilities<\/strong>. These advantages make bacterial systems a preferred choice for large-scale protein expression and production.<\/p>\n

Asia Pacific to Exhibit the Fastest Growth<\/strong><\/p>\n

The Asia Pacific region<\/strong> is projected to register the highest CAGR<\/strong> during the forecast period.Key factors driving regional growth include:<\/p>\n